THE US Food and Drug Administration (FDA) has approved Eucrisa (crisaborole) ointment to treat mild to moderate eczema (atopic dermatitis) in patients two years of age and older.
The PDE-4 inhibitor is not yet approved for marketing in Australia.
THE Pharmacy Board of Australia has opened public consultation on the draft registration standards and guidelines for a proposed Endorsement for scheduled medicines for pharmacists.
AS the Federal Government enters final negotiations for the First Pharmacy Programs Agreement (1PPA), the Remote and Isolated Pharmacist Association Australia (RIPAA) is calling for a dedicated funding pilot to support resident clinical pharmacists in Australia’s most isolated communities.
UK-BASED organisation GenM founder Heather Jackson (pictured) is on a mission to support pharmacies helping women through menopause with its MTick certification and accreditation.